• Helping you understand who owns the world, and how you can invest in it.
  • Follow us

Dyne Therapeutics, Inc.

Dyne Therapeutics, Inc.

Public
DYNT
United States
SectorHealthcare
CountryUnited States
Market cap3.23B
A clinical-stage biopharmaceutical company developing precision genetic medicines for severe neuromuscular and genetic diseases.

Where to buy Dyne Therapeutics, Inc. (DYNT)

DYNT trades on these platforms. Substox may earn a commission if you open an account through one of these links, at no cost to you. It never changes what the data on this page says. Substox is not a licensed financial adviser and this is not investment advice.

Similar public companies in Healthcare